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a  b  s  t  r  a  c  t
Background:  Clinical  guidelines  suggest  testing  for  respiratory  viruses  during  the  inﬂuenza  season,  but
are unclear  which  categories  of patients  on  the  intensive  care  unit  (ICU)  should  be tested.
Objective:  We  described  the  clinical  practice  of diagnostic  testing  for respiratory  virus  infections  in
patients  presenting  to ICU with  suspected  community-acquired  pneumonia  (CAP)  or hospital-acquired
pneumonia  (HAP).
Study design:  Prospective  observational  study  in consecutive  CAP  and  HAP  patients  with  an ICU stay  of
more  than  24 h in  two  tertiary  care  hospitals  in  The  Netherlands,  from  2011  to  December  2013.  The
proportion  of patients  receiving  diagnostic  testing  with  PCR  for the  presence  of  respiratory  viruses  in
respiratory  tract  specimens  was  determined.
Results:  In  total,  1452  patients  were  included,  of  which  712  patients  presented  with  CAP  and 740  with  HAP.
In  CAP,  282  of  712  (40%)  were  tested  for  respiratory  viruses  (190  of  417  (46%)  during  the  inﬂuenza  season).
In  HAP,  95 of  740 (13%)  were  tested  (50  of  372  (13%)  during  the  inﬂuenza  season).  Regardless  of  the  season,
virus  diagnostic  tests  were  ordered  signiﬁcantly  more  often  in patients  with  comorbidities,  and  in  those
presenting  with  elevated  CRP  and  leucopenia.  In  patients  who  were  tested  during  the  inﬂuenza  season,
the  prevalence  of  inﬂuenza  was  14%  in  patients  with  CAP  and  10%  in  those  with  HAP. Inﬂuenza  was  absent
during  the summer  in both  groups.
Conclusions:  Less  than  half  of patients  admitted  to  the  ICU with  suspected  pneumonia  were  tested  for  the
presence  of viral  pathogens,  either  in  or outside  the  inﬂuenza  season.
© 2016  The  Author(s).  Published  by Elsevier  B.V. This  is  an open  access  article  under  the CC  BY  license. BackgroundRespiratory virus infections are important causes of
ommunity-acquired pneumonia (CAP) and respiratory fail-
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ure both in children and adults [1]. Epidemiological studies show
that the prevalence of viral respiratory tract infections can be as
high as 41% in critically ill patients admitted to the intensive care
unit (ICU) with a suspected CAP, and up to 34% in hospital-acquired
pneumonia (HAP) [2–6]. Detection of such infections in critically
ill patients may  have important implications for infection control
measures such as isolation and, in case of (suspected) inﬂuenza,
rapid initiation of antiviral medication [7,8]. These measures have
an impact on ICU resource use, mandating clear assessment of
patients at risk of a viral respiratory tract infection.
A recent large retrospective study indicated that inﬂuenza infec-
tions are underdiagnosed in the critically ill [9]. However, current
international clinical guidelines on virus diagnostics are not clear
 under the CC BY license (http://creativecommons.org/licenses/by/4.0/).



















































Fig. 1. Flowchart of patient inclusion.8 F. van Someren Gréve et al. / Journ
bout which patients should receive testing in the ICU setting.
he Infectious Diseases Society of America/American Thoracic Soci-
ty (IDSA/ATS) consensus guidelines, as well as the International
uidelines for Management of Severe Sepsis and the European
espiratory Society/European Society for Clinical Microbiology
nd Infectious Diseases guidelines, state that testing for at least
nﬂuenza should be considered in adult patients admitted with sus-
ected respiratory infection during local epidemics [10–12], but all
re unclear if all patients admitted to the ICU with a suspected CAP
hould be tested for respiratory viruses. There are no recommen-
ations for virus testing in patients admitted to the ICU due to HAP.
he current practice of testing for the presence of viral pathogens
n critically ill patients with a suspected CAP or HAP is unknown.
. Objectives
The practice of diagnostic testing for viral respiratory infec-
ions was described in patients admitted to the ICU with clinical
ymptoms suggestive for CAP or HAP. Also, the prevalence of virus
nfections as detected during routine care was reported.
. Study design
.1. Study population
This study is part of a multi-center prospective cohort study,
n which consecutive patients admitted to the mixed ICUs of two
ertiary care hospitals in The Netherlands were enrolled between
anuary 1st 2011 and December 31st 2013 (clinicaltrials.gov Iden-
iﬁer: NCT01905033). For this study patients with suspected CAP
r HAP were included. Exclusion criteria were admissions with a
ength of ICU stay of < 24 h and transfers from another ICU. The
thics Committees of both participating centers approved an opt-
ut method of consent (protocol number 10-056C).
.2. Study deﬁnitions
A suspected respiratory tract infection at ICU admission was
eﬁned by empiric or targeted use of systemic antibiotics for a sus-
ected CAP or HAP initiated by the attending physicians, between
even days prior to, and two days after ICU admission. The most
ikely source of each infection was determined by assessment of
linical data, radiological imaging and culture results as ordered
y routine care, using strict diagnostic criteria. These criteria were
ased on CDC criteria as well as the International Sepsis Forum
onsensus Conference deﬁnitions for CAP and HAP, which were
dapted to the Dutch situation as described previously [13]. All
bservers were trained in these deﬁnitions before the start of
he study, and an electronic algorithm was used that alarmed the
esearchers when there were inconsistencies with other recorded
linical variables.
Respiratory virus diagnostics were deﬁned as in-house poly-
erase chain reaction (PCR) tests ordered as per discretion
f attending physicians on samples from the respiratory tract,
ither simplex or multiplex [14,15], for any of the following
iruses: inﬂuenza virus A and B, respiratory syncytial virus,
uman metapneumovirus, parainﬂuenza virus 1–4, human rhi-
ovirus, coronavirus, adenovirus, enterovirus, human bocavirus
nd parechovirus. Samples from the respiratory tract included
asopharyngeal swabs, throat swabs, bronchoalveolar lavage ﬂuid,
racheobronchial aspirates, sputum and pleural puncture ﬂuid.Abbreviations: CAP = community-acquired pneumonia; HAP = hospital-acquired
pneumonia; ICU = intensive care unit; LOS = length of stay.
3.3. Data analysis
The characteristics of patients who were tested were compared
to patients not tested using non-parametric descriptive statistics.
Numerical data was compared by Kruskal-Wallis tests, categorical
data by Chi-square tests. Subgroup analyses were performed for
the inﬂuenza season period and the period outside the season sep-
arately. Inﬂuenza season was  deﬁned between November 1st and
April 30th. The prevalence of viral infections in those who were
tested was reported. Treatment with oseltamivir was  recorded, and
the continuation, discontinuation or start of treatment was related
to inﬂuenza test results. All analyses were performed using SAS
9.2 (Cary, NC, USA). P values less than 0.05 were considered to
represent statistical differences.
4. Results
During the study period, a total of 8303 patients were admit-
ted to the ICU, of whom 2356 were excluded because of an ICU
stay of less than 24 h, 437 patients were transferred from another
ICU, and 4058 did not have a suspected pneumonia. In total, 712
patients were included with a suspected CAP, and 740 patients with
a suspected HAP (Fig. 1).
4.1. Proportion of patients tested for respiratory viruses
In the group of patients admitted to the ICU with a suspected
CAP, 282 of 712 patients (40%) were tested for respiratory viruses;
of patients admitted with a suspected HAP, 95 of 740 (13%) were
tested (P = <0.001).
4.2. Characteristics of tested and non-tested patients with
suspected CAP
Patients admitted with a suspected CAP who were tested,
signiﬁcantly more often had comorbidities (including chronic
obstructive pulmonary disease (COPD), chronic renal insufﬁciency
and immune deﬁciency) compared to those who  were not tested





















Baseline characteristics of patients admitted with a suspected CAP and HAP.
Suspected CAP Suspected HAP
Not tested (n = 430) Tested (n = 282) p value Not tested (n = 645) Tested (n = 95) p value
Age, median years (Q1, Q3) 61.0 (48.0, 71.0) 62.0 (48.0, 72.0) 0.28 65.0 (55.0, 73.0) 59.0 (50.0, 68.0) <0.001
Male,  n (%) 289 (67%) 153 (54%) <0.001 414 (64%) 62 (65%) 0.84
BMI,  median (Q1, Q3) 24.8 (22.5, 27.9) 24.7 (21.5, 29.0) 0.73 24.8 (22.2, 28.1) 23.4 (20.4, 27.5) 0.007
Medical  admission, n (%) 363 (84%) 279 (99%) <0.001 504 (78%) 89 (94%) <0.001
Hospital days prior to ICU admission, median (Q1, Q3) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.88 8.0 (4.0, 17.0) 8.0 (4.0, 18.0) 0.70
Comorbidities
COPD,  n (%) 62 (14%) 73 (26%) <0.001 101 (16%) 19 (20%) 0.28
Congestive  heart failure, n (%) 24 (6%) 17 (6%) 0.80 43 (7%) 5 (5%) 0.60
Diabetes  mellitus, n (%) 77 (18%) 59 (21%) 0.32 125 (19%) 17 (18%) 0.73
Chronic  renal insufﬁciency, n (%) 41 (10%) 41 (15%) 0.041 60 (9%) 17 (18%) 0.010
Malignancy, n (%) 39 (9%) 24 (9%) 0.80 126 (20%) 15 (16%) 0.39
Splenectomy, n (%) 1 (0%) 0 (0%) 0.42 6 (1%) 0 (0%) 0.35
Immune  deﬁciency, n (%)a 48 (11%) 84 (30%) <0.001 71 (11%) 42 (44%) <0.001
APACHE IV Score, median (Q1, Q3) 76.0 (59.0, 104.0) 75.5 (59.0, 94.0) 0.39 75.0 (62.0, 93.0) 87.0 (70.0, 100.0) <0.001
Acute  Physiology Score, median (Q1,Q3) 64.0 (47.5, 92.0) 61.0 (46.0, 77.0) 0.023 63.0 (50.0, 80.0) 71.0 (61.0, 84.0) 0.005
SOFA  score on admission, median (Q1, Q3) 7.0 (5.0, 9.0) 7.0 (5.0, 9.0) 0.50 7.0 (5.0, 9.0) 9.0 (6.0, 10.0) <0.001
In  the ﬁrst 24 h of admission
Highest central body temperature, median ◦C (Q1,Q3) 37.7 (36.8, 38.5) 37.8 (37.0, 38.6) 0.044 38.0 (37.3, 38.7) 38.0 (37.4, 38.7) 0.90
First  measured CRP, median mg/L (Q1, Q3) 40.0 (5.0, 154.0) 135.0 (42.0, 235.0) <0.001 114.5 (51.0, 213.0) 160.0 (92.0, 282.0) 0.001
Highest  leucocytes, median cells·109/L (Q1, Q3) 14.6 (10.4, 19.0) 11.7 (7.9, 17.7) <0.001 14.8 (10.4, 19.9) 12.5 (2.1, 19.4) 0.011
Leucopenia, n (%)b 43 (10%) 48 (17%) 0.006 44 (7%) 26 (27%) <0.001
Use  of vasoactive medication >1 h, n (%) 262 (61%) 170 (60%) 0.86 400 (62%) 65 (68%) 0.23
Acute  renal failure, n (%) 42 (10%) 42 (15%) 0.038 77 (12%) 16 (17%) 0.18
Highest  serum lactate, median mmol/L (Q1, Q3) 2.8 (1.7, 4.8) 2.2 (1.4, 3.2) <0.001 1.9 (1.3, 3.3) 1.8 (1.3, 2.9) 0.74
Characteristics of patients tested for respiratory viruses were compared to patients who  were not tested. Abbreviations: APACHE IV = Acute Physiology and Chronic Health Evaluation IV; BMI  = body mass index; CAP = community-
acquired pneumonia; COPD = chronic obstructive pulmonary disease; CRP = C-reactive protein; HAP = hospital-acquired pneumonia; ICU = intensive care unit; SOFA = sequential organ failure assessment.
a Immunodeﬁciency was deﬁned as a history of solid organ or stem cell transplantation, infection with the human immunodeﬁciency virus, hematological malignancy, use of immunosuppressive medication (pred-
nisone  >0.1 mg/kg for >3 months, prednisone >75 mg/day for >1 week, or equivalent), chemotherapy/radiotherapy in the year before ICU admission, and any known humoral or cellular immune deﬁciency.
b Leucopenia was  deﬁned as <4 × 109/L leucocytes.
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igniﬁcantly lower acute physiology score (APS), while the Acute
hysiology and Chronic Health Evaluation IV (APACHE IV) and
equential Organ Failure Assessment (SOFA) score upon admission
id not differ. Also, tested patients had higher C-reactive protein
CRP) levels, more often leucopenia, and more often acute renal
ailure compared to non-tested patients.
.3. Characteristics of tested and non-tested patients with
uspected HAP
Patients admitted with a suspected HAP who were tested, more
ften had chronic renal insufﬁciency and immune deﬁciency com-
ared to non-tested patients (Table 1). Tested patients also had
igniﬁcantly higher CRP levels, more often leucopenia, acute renal
ailure and higher severity of all illness scores compared to patients
ith a suspected HAP who were not tested.
.4. Seasonal inﬂuence on viral diagnostic testing
In the inﬂuenza season, 190 of 417 (46%) patients admitted with
 suspected CAP were tested for respiratory viruses; outside the
eason 92 of 295 (32%) were tested (P = <0.001). Of the patients
dmitted with a suspected HAP, 50 of 372 (13%) in and 45 of 368
12%) outside the season were tested (P = 0.62). In CAP patients
dmitted within the inﬂuenza season, baseline characteristics were
ompared between tested and non-tested patients, showing simi-
ar differences in characteristics as in the total group of suspected
AP patients, with the exception of the APS, which did not differ
etween tested and non-tested patients (Supplementary Table S1).
.5. Timing and results of diagnostic tests
The prevalence of viral respiratory tract infections in tested
atients differed between suspected CAP and HAP, and between
atients admitted in and outside the inﬂuenza season (Table 2).
n the inﬂuenza season, viruses were found in 65 of 190 (34%) of
uspected CAP patients, and in 17 of 50 (34%) of suspected HAP
atients. Outside the inﬂuenza season, 17 of 92 (19%) suspected
AP patients and 7 of 45 (16%) suspected HAP patients tested posi-
ive for at least 1 virus. In the inﬂuenza season, the most prevalent
athogen was inﬂuenza virus (26 of 190 (14%) in suspected CAP
nd 5 of 49 (10%) in suspected HAP). Outside the inﬂuenza season,
nﬂuenza virus was not found. Ordering of virus tests was  mostly
erformed on the day of ICU admission, in both suspected CAP and
AP cases (Fig. 2). In all patients that were tested for inﬂuenza virus,
he results of the test changed antiviral prescription in 157/367
43%) of patients: in 149 of 158 (94%) patients oseltamivir treatment
as discontinued after a negative test, and in 8 of 9 (89%) patients
ithout empirical antiviral treatment, oseltamivir was  started after
 positive test result.
. Discussion
Our study shows that 46% of patients admitted to the ICU with a
uspected CAP during the inﬂuenza season was tested for the pres-
nce of viral pathogens, whereas 32% of CAP patients was tested
utside the season. Patients admitted with a suspected HAP were
ested in 13% and 12% in both seasons respectively. Regardless of the
eason, patients with comorbidities (including COPD and immune
eﬁciency) and inﬂammation biomarkers (elevated CRP and leu-
openia) were tested signiﬁcantly more often. In patients who  were
ested, the prevalence of viral respiratory tract infections was sim-
lar in suspected CAP and HAP cases.
The results of this study show that less than half of patients
dmitted to the ICU with a suspected pneumonia were tested forFig. 2. Timing of virus diagnostic tests, as performed by attending physicians.
Abbreviations: CAP = community-acquired pneumonia; HAP = hospital-acquired
pneumonia; ICU = intensive care unit.
viral infections. This may reﬂect a lack of awareness and clear clin-
ical guidelines on virus diagnostics for ICU patients admitted with
a suspected CAP or HAP. While international guidelines are unclear
if all critically ill patients with suspected pneumonia for inﬂuenza
during the winter season should be tested, the IDSA/ATS guide-
lines also state that “Patients with CAP should be investigated for
speciﬁc pathogens that would signiﬁcantly alter standard (empirical)
management decisions, when the presence of such pathogens is sus-
pected on the basis of clinical and epidemiologic clues” [10]. Although
a positive virus test does not necessarily indicate virus-related
or virus-induced critical illness [16,17], detecting an inﬂuenza
infection has consequences for antiviral treatment and quaran-
tine measures [7,8]. Consequently, some experts advise testing for
inﬂuenza in all patients admitted with severe pulmonary infection
during the inﬂuenza season [18–20]. Indeed, our study shows that
the results of the inﬂuenza PCR changed the oseltamivir prescrip-
tion in 43% of patients. Whether testing for non-inﬂuenza viruses
should be routinely performed in patients with severe pneumo-
nia remains unclear. The US Healthcare Infection Control Practices
Advisory Committee recommends droplet isolation for infections
with adenovirus and rhinovirus in adults [25], however the clini-
cal signiﬁcance of most non-inﬂuenza viruses in adult ICU patients
in particular remains controversial [21–24]. More research on the
clinical burden of non-inﬂuenza viruses in patients with severe
pneumonia is needed to determine if routine testing for other res-
piratory viruses is also warranted. Furthermore, more insight in the
disease burden that comes with viral infection may  limit unneces-
sary use of antibiotics.
Alternatively, low prevalence of testing may be due to difﬁ-
culties in establishing a clinical suspicion of a viral respiratory
tract infection in the critically ill. As testing in our study was
more often performed in patients who  had more comorbidities,
higher CRP and leucopenia, physicians may believe that viral infec-
tion is characterized by these characteristics. However, symptoms
of inﬂuenza-like-illness may  be mild or absent in hospitalized
patients [26], and there is yet no clinical algorithm to distinguish
viral pneumonia from bacterial pneumonia [1]. Although the risk
factors for more severe and complicated viral respiratory tract
infections are well established, such as chronic lung- and heart dis-
ease and immunodeﬁciency, this does not imply that ICU patients
with these characteristics are at a higher risk of having a viral infec-
tion on admittance [3]. Selective testing in the ICU setting may
lead to underdiagnosis of viral infections. Indeed, a large retrospec-
tive study comparing the predicted amount of inﬂuenza-related
ICU admissions to the reported admissions with an inﬂuenza diag-
F. van Someren Gréve et al. / Journal of Clinical Virology 83 (2016) 37–42 41
Table  2
Prevalence of viral respiratory tract infections as found by routine diagnostics.




Suspected HAP in inﬂuenza
seasona
Suspected HAP  outside
inﬂuenza seasona
Patients tested (n) Virus
positive (n,
%)
Patients tested (n) Virus
positive (n,
%)
Patients tested (n) Virus
positive (n,
%)
Patients tested (n) Virus
positive (n,
%)
adenovirus 173 3 (2%) 88 1 (1%) 44 0 (0%) 39 1 (3%)
bocavirus 172 0 (0%) 88 0 (0%) 44 0 (0%) 39 0 (0%)
coronavirus 179 13 (7%) 89 1 (1%) 44 4 (9%) 39 0 (0%)
enterovirus 134 1 (1%) 73 0 (0%) 27 0 (0%) 24 0 (0%)
human metapneumovirus 173 9 (5%) 88 0 (0%) 44 1 (2%) 39 2 (5%)
inﬂuenza virus 190 26 (14%) 89 0 (0%) 49 5 (10%) 39 0 (0%)
parechovirus 134 0 (0%) 73 0 (0%) 27 0 (0%) 24 0 (0%)
parainﬂuenza virus 173 1 (1%) 88 4 (5%) 44 2 (5%) 39 3 (8%)
rhinovirus 179 13 (7%) 89 12 (14%) 44 3 (7%) 39 2 (5%)
respiratory syncytial virus 179 5 (3%) 89 2 (2%) 45 3 (7%) 39 0 (0%)










































fbbreviations: CAP = community-acquired pneumonia; HAP = hospital-acquired pn
a Inﬂuenza season was  deﬁned from November 1st to April 30th.
b A patient with an infection with more than one virus counts as 1 virus-positive
osis, suggested that over 90% of cases are either not diagnosed
r not reported [9]. Small prospective observational studies show
hat 50–70% of detected inﬂuenza infections were unsuspected by
he attending physicians [27,28]. In addition, in the current study
he majority of virus tests was ordered in the ﬁrst 2 days of ICU
dmission. Interestingly however, there were also virus tests being
rdered up to 7 days after ICU admission. While we do not know
he reasons for ordering these tests, it may  suggest that an infection
ith a respiratory virus may  have been occasionally overlooked at
CU admission. Taken together, one could suggest that viral testing
f ICU patients with a suspected respiratory tract infection should
ot depend on symptom severity.
Remarkably, the frequency of viral testing did not differ very
uch between in and outside the inﬂuenza season. Outside the
nﬂuenza season, the prevalence of viral infection dropped but was
till 19% in CAP and 16% in HAP cases. Whether this indicates that
irus testing should also be performed outside the season cannot be
oncluded from our study, because only a selected group of patients
ere tested. Of note, inﬂuenza virus was absent outside the season.
HAP patients were tested signiﬁcantly less often for viral infec-
ions than CAP patients. However, in the tested patients, the overall
revalence of viral infections was similar in CAP and HAP patients.
ur data may  suggest that HAP patients also have a considerable
isk of having a viral infection, which is in accordance with retro-
pective studies on the prevalence of viral infections in the ICU that
nclude HAP [2,6].
The strength of the current study design is based on the fact that
uspected cases of CAP and HAP were prospectively assessed by a
rained team of research physicians according to validated deﬁni-
ions, and that the attending medical staff was not aware of our
tudy aims, which otherwise could have interfered with the actual
ractice of performing viral diagnostic tests. An important limi-
ation of the current study design is that the prevalence of viral
nfections was not systematically tested in all patients with a sus-
ected respiratory infection, which hampers the estimation of the
revalence of viral respiratory tract infections.
In conclusion, our study shows that less than half of the ICU
atients admitted with a suspected pneumonia, either in or outside
he inﬂuenza season, are tested for the presence of viral pathogens
nd that the decision to test seems primarily to depend on patient
omorbidities and inﬂammation biomarker proﬁle. As guidelines
learly recommend to consider testing for inﬂuenza virus during
ocal epidemics, and detecting inﬂuenza virus has consequences
or treatment and isolation measures, there is room for increasingia.
t.
routine inﬂuenza virus testing in patients with suspected CAP and
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